House Dems Call Out Pharma R&D Claims

(MedPage Today) -- Lawmakers at a congressional hearing Thursday were openly dismissive of drug industry claims that higher prices are needed to fund research and development (R&D) for new products.Rep. Carolyn Maloney (D-N.Y.), chair of...